Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
EP300 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
EP300 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Pharma Frontiers
8 min read
BRD4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
BRD4 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Pharma Frontiers
8 min read
KDM1A Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
KDM1A target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
DNMT1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
DNMT1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
HDAC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
HDAC1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
TOP2A Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TOP2A target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
TOP1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
TOP1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
AURKA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
AURKA target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
ERBB3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
ERBB3 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
FGFR4 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
FGFR4 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Latest Hotspot
8 min read
FGFR1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
FGFR1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.
Pharma Frontiers
8 min read
CDK6 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
9 July 2026
CDK6 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, competition, IP and R&D strategy.